ClinicalLiverDisease
@CLD_Learning
Followers
12K
Following
486
Media
798
Statuses
2K
Clinical Liver Disease (CLD) is an official digital learning resource of The American Association for the Study of Liver Diseases.
Joined October 2011
RT @AASLDtweets: Discover the latest insights in liver disease management in the FINAL issue of Clinical Liver Disease! @CLD_Learning https….
0
2
0
Check out History of Hepatology collection on landmark events of our field!. Full collection- Liver biopsy - Liver transplant -. Liver surgery -.
0
3
5
*New CLD series*.@BrettEFortune & Shari Royal expertly curated series on improving Quality of Care in Cirrhosis. An increasingly important topic. Full series: Sample content:.
0
6
15
The evidence for fecal microbiota transplantation efficacy in liver disease continues to emerge . Read a comprehensive overview of the current state of play here: .
1
5
10
Addictive disorders are increasingly impacting liver disease outcomes . J Mellinger @lykhaque edit this crucial CLD series on addiction and liver disease. A must read! . Full series: . Sample content:.
0
10
26
Opportunities for harnessing digital technologies to improve outcomes in cirrhosis. A great overview by the field leaders @jlouissaint89 @TiffanyWuMD .
⌚️Emerging #Digital Technologies to Help Patients with Cirrhosis📱 ‼️. ✅out this review in @AASLDtweets @CLD_Learning where @TiffanyWuMD and I discuss how digital tools are reshaping #liver care!. #LiverTwitter.
1
4
6
*NEW SERIES* edited by @serperm @yucaspice.Functional status is critical in determining outcomes in cirrhosis. Nutrition: Untangling sarcopenia, frailty, and fitness: Series link (when all published)
1
19
32
Check out new articles added to our HCC series from debate on immunotherapy in LT, expansion of surgical candidates, biomarkers and updates on LT policy.
0
6
18
A succinct review on management of hepatitis B reactivation. Risks and decision for prophylaxis are based on serologic status of patients and type of immunosuppressive therapy. Helpful figure to guide decision making.
0
18
30
The role of immunotherapy in the evolving landscape of HCC treatment in the context of liver transplant. Promising use needs to be balanced with allograft rejection.Expert opinion suggest a minimal of 12-week washout, more data needed.
0
8
22
2 more from our Hep B elimination series -Elimination: -Functional cure (Anna Lok):.3%–5% after 10 yrs of nucleos(t)ide analogs; 8%–14% after 3–5 years of 48-wks of peg interferon. Trials also discussed.
1
9
11
The most in-depth and interesting article on the evolution of the Cardio-Hepatology field, a truly unique relationship:. See the entire series of History of Hepatology collection here:.
0
13
28
Check out two recently published articles on the advances in Hepaititis B and Hepatitis D treatments! .
0
7
13
RT @CLD_Learning: @agud__MD @AlexanderPodboy explore the ever expanding field of endo-bariatric therapies in treating MASLD. Endo Balloon &….
0
8
0
RT @CLD_Learning: @RobertFontanaMD & colleagues @MichiganLiver guide us through the challenging (& common) scenario of how to establish a d….
0
4
0
Two interesting articles on infantile cholestasis. 1. Renal lesion associations: 2. Biliary atresia case:. @anouti_ahmad @BAREInc_org
0
4
7
CLD series is curated by our Guest Editors to bring articles together to capture intent of the series. Check out the new content added to the "Pregnancy and Liver Disease" series.
0
3
6
Metabolic Disorders play an important role in modifying hepatitis B outcomes. From our upcoming "Current Challenges in the Management of Chronic Hepatitis B Infection" series collection:.
0
7
7
Editor-in-Chief Dr. Joseph K. Lim's editorial @CLD_Learning . Clinical Liver Disease: Legacy of innovation in hepatology education.
0
5
12
Check out this review and interview with the author on inpatient management of fluid overload in patients with decompensated cirrhosis.
0
7
19